News & Events about Natera Inc.
Natera, Inc. (NASDAQ:NTRA Get Rating) CFO Michael Burkes Brophy sold 949 shares of the stock in a transaction on Monday, April 24th. The shares were sold at an average price of $54.98, for a total value of $52,176.02. Following the sale, the chief financial officer now owns 67,197 shares in the ...
Natera, Inc. (NASDAQ:NTRA Get Rating) CEO Steven Leonard Chapman sold 885 shares of Natera stock in a transaction that occurred on Monday, April 24th. The shares were sold at an average price of $54.98, for a total transaction of $48,657.30. Following the sale, the chief executive officer now owns ...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced new data on its Signatera molecular residual disease (MRD) test being presented at the annual meeting of the American Association for Cancer Research (AACR) taking place April 14 19, 2023. Natera and its...
Ticker Report
2 months ago
Natera, Inc. (NASDAQ:NTRA Get Rating) insider Jonathan Sheena sold 5,000 shares of Natera stock in a transaction on Monday, April 3rd. The shares were sold at an average price of $54.02, for a total transaction of $270,100.00. Following the completion of the sale, the insider now directly ...